Novartis ( NVS ) announced the submission of its Biologic License Application (BLA) for meningitis B vaccine candidate Bexsero to …read more
Novartis Submits Bexsero to FDA for Marketing Approval – Analyst Blog
- by Bob Mitchell
Novartis ( NVS ) announced the submission of its Biologic License Application (BLA) for meningitis B vaccine candidate Bexsero to …read more